BANGKOK, June 2 (TNA) – The World Health Organization on June 1 approved the emergency use of the COVID-19 vaccine developed by Sinovac of China, the Chinese embassy in Thailand said.
WHO approved the use of CoronaVac developed by Sinovac Biotech, a Chinese pharmaceutical company.
WHO announced on June 1 that it advised people aged 18 years and over be inoculated with two jabs of the vaccine against COVID-19 and both doses be 2-4 weeks apart.
WHO’s Strategic Advisory Group of Experts (SAGE) said the vaccine of Sinovac prevented COVID-19 symptoms in 51% of vaccine recipients and averted severe illnesses and hospital admissions in 100% of studied vaccine recipients. (TNA)
